“Retirement Secret” Showed 995% Gain Last Time We Shared It

Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.

Find out why right here (and see what you can do to get in too with just a few dollars).

Brett Monia Biography and Net Worth

CEO of Ionis Pharmaceuticals

Dr. Monia is the chief executive officer, a member of the board of directors and a founding scientist of Ionis Pharmaceuticals. His contributions at Ionis include research into the medicinal chemistry and mechanisms of action of RNA-targeting modalities to treat human diseases, most notably antisense-based therapeutic strategies. Dr. Monia has extensive experience across a range of therapeutic areas, including oncology, metabolic disease, inflammation, neurological disease and cardiovascular disease, which have resulted in a broad range of successful clinical achievements and in marketing approvals for new medicines.

Dr. Monia has published more than 200 primary research manuscripts, reviews and book chapters, and is an inventor on more than 100 issued patents. He serves as a senior editor for the journal Nucleic Acid Therapeutics. He is on the board of directors of Cognition Therapeutics and the board of directors of Dynacure. He has also served as president of the Oligonucleotide Therapeutics Society (OTS). Dr. Monia is also an adjunct professor of biology at San Diego State University where he lectures at the graduate level on pharmacology.

Dr. Monia received his Ph.D. in Pharmacology at the University of Pennsylvania and B.S. degrees in Molecular Biology and Analytical Chemistry at Stockton State College in Pomona, New Jersey.

What is Brett P. Monia's net worth?: The estimated net worth of Brett P. Monia is at least $7.27 million as of February 16th, 2024. Dr. Monia owns 173,751 shares of Ionis Pharmaceuticals stock worth more than $7,269,742 as of April 25th. This net worth estimate does not reflect any other investments that Dr. Monia may own. Additionally, Dr. Monia receives an annual salary of $1,710,000.00 as CEO at Ionis Pharmaceuticals. Learn More about Brett P. Monia's net worth.
How old is Brett P. Monia?: Dr. Monia is currently 63 years old. There are 6 older executives and no younger executives at Ionis Pharmaceuticals. Learn More on Brett P. Monia's age.
What is Brett P. Monia's salary?: As the CEO of Ionis Pharmaceuticals, Inc., Dr. Monia earns $1,710,000.00 per year. Learn More on Brett P. Monia's salary.
How do I contact Brett P. Monia?: The corporate mailing address for Dr. Monia and other Ionis Pharmaceuticals executives is 2855 GAZELLE COURT, CARLSBAD CA, 92010. Ionis Pharmaceuticals can also be reached via phone at (760) 931-9200 and via email at [email protected]. Learn More on Brett P. Monia's contact information.
Has Brett P. Monia been buying or selling shares of Ionis Pharmaceuticals?: Brett P. Monia has not been actively trading shares of Ionis Pharmaceuticals during the past quarter. Most recently, Brett P. Monia sold 387 shares of the business's stock in a transaction on Friday, February 16th. The shares were sold at an average price of $44.49, for a transaction totalling $17,217.63. Following the completion of the sale, the chief executive officer now directly owns 173,751 shares of the company's stock, valued at $7,730,181.99. Learn More on Brett P. Monia's trading history.
Who are Ionis Pharmaceuticals' active insiders?: Ionis Pharmaceuticals' insider roster includes C. Bennett (EVP), Spencer Berthelsen (Director), Brian Birchler (EVP), Onaiza Cadoret-Manier (EVP), Breaux Castleman (Director), Stanley Crooke (Chairman), Allene Diaz (Director), Richard Geary (EVP), Elizabeth Hougen (CFO), Joseph Klein, III (Director), Brett Monia (CEO), Frederick Muto (Director), Patrick O'Neil (EVP), B. Parshall, Esq. (Director), Eugene Schneider (EVP), and Eric Swayze (EVP). Learn More on Ionis Pharmaceuticals' active insiders.
Are insiders buying or selling shares of Ionis Pharmaceuticals?: During the last year, insiders at the sold shares 28 times. They sold a total of 291,805 shares worth more than $14,352,782.01. The most recent insider tranaction occured on April, 16th when EVP Joseph Baroldi sold 4,006 shares worth more than $166,649.60. Insiders at Ionis Pharmaceuticals own 2.7% of the company. Learn More about insider trades at Ionis Pharmaceuticals.
Information on this page was last updated on 4/16/2024.

Brett P. Monia Insider Trading History at Ionis Pharmaceuticals

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/16/2024	Sell	387	$44.49	$17,217.63	173,751
2/2/2024	Sell	23,501	$49.37	$1,160,244.37	174,138
1/25/2024	Sell	2,285	$51.75	$118,248.75	151,851
1/17/2024	Sell	32,059	$50.42	$1,616,414.78	154,136
12/21/2023	Sell	17,500	$49.29	$862,575.00	118,111
12/14/2023	Sell	24,000	$49.58	$1,189,920.00	118,111
10/12/2023	Sell	3,770	$46.00	$173,420.00	118,111
7/7/2023	Sell	18,650	$42.25	$787,962.50	121,724
5/22/2023	Sell	4,931	$40.14	$197,930.34	140,374
2/6/2023	Sell	24,651	$40.69	$1,003,049.19	145,305
1/18/2023	Sell	25,066	$39.49	$989,856.34	120,863
4/1/2022	Sell	355	$37.49	$13,308.95	88,662
3/1/2021	Sell	236	$54.28	$12,810.08	50,350
12/4/2020	Sell	23,840	$51.04	$1,216,793.60	52,719
12/2/2020	Sell	21,160	$51.32	$1,085,931.20	50,039
9/1/2020	Sell	314	$53.70	$16,861.80	29,193
1/2/2020	Sell	173	$60.25	$10,423.25	16,285
11/20/2019	Sell	5,776	$60.01	$346,617.76	16,458
7/2/2019	Sell	210	$66.40	$13,944.00	22,444
1/2/2019	Sell	214	$53.50	$11,449.00	16,051
11/23/2018	Sell	34,000	$55.00	$1,870,000.00	49,841
8/27/2018	Sell	16,493	$54.00	$890,622.00	24,834
7/24/2018	Sell	156	$47.03	$7,336.68	15,841
1/16/2018	Sell	2,821	$51.76	$146,014.96	18,604
1/2/2018	Sell	163	$50.00	$8,150.00	11,782
7/3/2017	Sell	309	$51.35	$15,867.15	11,935
1/17/2017	Sell	2,502	$46.29	$115,817.58	9,287
1/3/2017	Sell	309	$48.60	$15,017.40	8,181
12/20/2016	Sell	130	$52.48	$6,822.40	7,872
1/4/2016	Sell	127	$61.00	$7,747.00	4,358
6/8/2015	Sell	7,600	$66.22	$503,272.00
7/31/2014	Sell	79	$31.50	$2,488.50
6/11/2013	Sell	9,375	$23.76	$222,750.00

Brett P. Monia Buying and Selling Activity at Ionis Pharmaceuticals

Ionis Pharmaceuticals Company Overview

Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an antisense injection for the treatment of polyneuropathy caused by hereditary transthyretin amyloidosis in adults; and WAYLIVRA, an antisense medicine for treatment for familial chylomicronemia syndrome (FCS) and familial partial lipodystrophy. It also develops medicines for various indications that are in phase 3 study, including Eplontersen as a monthly self-administered subcutaneous injection to treat all types of ATTR; Olezarsen for patients with FCS and severe hypertriglyceridemia (SHTG); Donidalorsen for patients with hereditary angioedema; ION363 for patients with amyotrophic lateral sclerosis; Tofersen to inhibit the production of superoxide dismutase 1; Pelacarsen for patients with established cardiovascular disease and elevated lipoprotein(a); and Bepirovirsen to inhibit the production of viral proteins associated with hepatitis B virus. In addition, the company develops IONIS-FB-LRx to inhibit the production of complement factor B and the alternative complement pathway; and ION224 to reduce the production of diacylglycerol acyltransferase 2. It has a strategic collaboration with Biogen for the treatment of neurological disorders; and collaboration and license agreement with Metagenomi, Inc, AstraZeneca, Bayer AG, GlaxoSmithKline plc, Novartis, Roche, Swedish Orphan Biovitrum AB, and PTC Therapeutics. The company was incorporated in 1989 and is based in Carlsbad, California.

Today's Range

Now: $41.84

$41.58

$42.73

50 Day Range

MA: $43.40

$40.68

$47.41

2 Week Range

Now: $41.84

$34.32

$54.44

Volume

1,142,805 shs

Average Volume

1,136,584 shs

Market Capitalization

$6.10 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.39

“Retirement Secret” Showed 995% Gain Last Time We Shared It

From Stansberry Research | Ad

Find out why right here (and see what you can do to get in too with just a few dollars).

Brett Monia Biography and Net Worth

What is Brett P. Monia's net worth?

How old is Brett P. Monia?

What is Brett P. Monia's salary?

How do I contact Brett P. Monia?

Has Brett P. Monia been buying or selling shares of Ionis Pharmaceuticals?

Who are Ionis Pharmaceuticals' active insiders?

Are insiders buying or selling shares of Ionis Pharmaceuticals?